American Academy of Allergy, Asthma & Immunology, Feb. 24 to 27
The annual meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI) was held from Feb. 24 to 27 in San Antonio and attracted participants from around the world, including clinicians, academicians, allied health professionals, and other…
Learn MoreNovo Nordisk to Cut Insulin Prices by Up to 75 Percent
TUESDAY, March 14, 2023 (HealthDay News) — Novo Nordisk Inc. on Tuesday became the third drug company to say it will slash prices on some of its insulin products.Starting in January 2024, there will be a 75 percent price cut for NovoLog and NovoLog M…
Learn MoreU.S. to Tighten Control of PFAS Chemicals in Drinking Water
TUESDAY, March 14, 2023 (HealthDay News) — U.S. water utilities will be required to remove certain “forever chemicals” from drinking water as the Biden administration sets first-ever limits on perfluoroalkyl and polyfluoroalkyl compounds, better know…
Learn MoreAI Model Can Help Identify Ulcerative Colitis Remission, Activity
TUESDAY, March 14, 2023 (HealthDay News) — An artificial intelligence (AI) model can distinguish histological remission from activity in biopsies of ulcerative colitis (UC) and can predict flare-ups, according to a study published online March 3 in G…
Learn MoreNew Model Predicts Two-Year Risk for Fall Injuries in Nursing Home Residents
TUESDAY, March 14, 2023 (HealthDay News) — A new risk prediction model can identify residents of nursing homes at greatest risk for fall-related injuries, according to a study published online March 8 in the Journal of the American Geriatrics Society…
Learn MorePsychiatric, Learning Disorders Common in Students Who Make School Threats
TUESDAY, March 14, 2023 (HealthDay News) — Students who make threats toward others at school have diverse psychiatric profiles and often do not receive recommended treatments, according to a study recently published in the Journal of the American Aca…
Learn MoreACC: Coordinated Intervention Increases Rx for Evidence-Based T2DM Therapies
TUESDAY, March 14, 2023 (HealthDay News) — A coordinated, multifaceted intervention increases prescription of three groups of evidence-based therapies in adults with type 2 diabetes and atherosclerotic cardiovascular disease (CVD), according to a stu…
Learn MoreACC: Healthy Sleep Pattern Cuts Risk for Premature Death
TUESDAY, March 14, 2023 (HealthDay News) — A healthy sleep pattern is associated with a lower risk for premature mortality and higher life expectancy among U.S. adults, according to a study presented at the annual meeting of the American College of C…
Learn MoreFDA Approves First Treatment for Rett Syndrome
TUESDAY, March 14, 2023 (HealthDay News) – The U.S. Food and Drug Administration has approved Daybue (trofinetide) for the treatment of Rett syndrome in adult and pediatric patients aged 2 years and older.Approval was based on results from the phase 3…
Learn MoreNew Nasal Spray for Migraines Approved by FDA
MONDAY, March 13, 2023 (HealthDay News) — The U.S. Food and Drug Administration has approved Pfizer’s zavegepant (Zavzpret), a calcitonin gene-related peptide receptor antagonist nasal spray meant to treat severe headache pain, the company announced …
Learn More